Preclinical evaluation of cancer drugs
The discovery that a certain molecule could be used as a new therapeutic against a certain cancer type is often made in the lab. However, before new medicines based on these molecules can be used to treat patients, they need to be extensively tested and validated. Many CRIG studies are focused on this pre-clinical aspect of cancer research and thereby bridge the gap between basic research and clinical practice.
CRIG group leaders
Other CRIG members
- dr. Inna Afonina (PhD)
- dr. Jan Willem Bek (PhD)
- Eva Blondeel
- dr. Delfien Bogaert (MD, PhD)
- Helena Braet
- Nathan Carpentier
- dr. Dorien Clarisse (PhD)
- dr. Sarah Cosyns (PhD)
- dr. Willem Daneels (MD)
- Martijn de Jong
- dr. Renate De Smedt (PhD)
- Els De Smet
- dr. Elly De Vlieghere (PhD)
- Fanny De Vloed
- dr. Bieke Decaesteker (PhD)
- Jill Deleu
- Larissa Deneweth
- Lisa Depestel
- dr. Benedicte Descamps (PhD)
- Inge D'Hont
- prof. Matthias D’hooghe (PhD)
- Aline Eggermont
- Sam Ernst
- Charlotte Fieuws
- dr. Behrouz Hassannia (PhD)
- Nathalie Heynickx
- dr. Els Janssens (PhD)
- dr. Lore Lapeire (MD, PhD)
- dr. Sander Lefere (MD, PhD)
- dr. Kai Ling Liang (PhD)
- Siebe Loontiens
- Amber Louwagie
- Christophe Mangodt
- dr. Pieterjan Merckx (PhD)
- dr. Valerie De Meulenaere (PhD)
- dr. Liselot M. Mus (PhD)
- dr. Viacheslav Mylka (PhD)
- dr. Parisa Norouzitallab (PhD)
- Carolina Nunes
- dr. Bogdan Parakhonskiy (PhD)
- dr. Tim Pieters (PhD)
- Lien Provez
- Muhammad Rishfi
- dr. Bart Roman (PhD)
- Nidda Saeed
- Ellen Sanders
- dr. Joachim T. Siaw (PhD)
- prof. Jens Staal (PhD)
- dr. Jonas Steenbrugge (PhD)
- Eva Terras
- dr. Laurens Van Camp (MD)
- Leen Van de Sande
- Elias Van De Vijver
- Stephane Van Haver
- prof. Jolanda van Hengel
- Jolien Van Laere
- dr. Sandra Van Lint (PhD)
- Maaike Van Trimpont
- dr. Sophie Van Welden (PhD)
- Katrien Vandemeulebroecke
- Jolien Vanhooren
- prof. Christian Vanhove (PhD)
- dr. Rein Verbeke (PhD)
- dr. Jeroen Verhoeven (PhD)
- Nurten Yigit